![]() |
Volumn 58, Issue 4, 2002, Pages 243-245
|
Cyclosporin increases the exposure to tezosentan, an intravenous dual endothelin receptor antagonist
a
|
Author keywords
Cyclosporin; Pharmacokinetic interaction; Tezosentan
|
Indexed keywords
CYCLOSPORIN A;
OPTORAL;
TEZOSENTAN;
CYCLOSPORIN;
ENDOTHELIN RECEPTOR;
IMMUNOSUPPRESSIVE AGENT;
PYRIDINE DERIVATIVE;
TETRAZOLE DERIVATIVE;
VASODILATOR AGENT;
ARTICLE;
CONTROLLED STUDY;
DRUG EXPOSURE;
DRUG TOLERABILITY;
ELECTROCARDIOGRAM;
HEADACHE;
HOT FLUSH;
HUMAN;
HUMAN EXPERIMENT;
MALE;
NAUSEA;
NORMAL HUMAN;
PRIORITY JOURNAL;
VOMITING;
AREA UNDER THE CURVE;
CLINICAL TRIAL;
COMPARATIVE STUDY;
CONTROLLED CLINICAL TRIAL;
DOSE RESPONSE;
DRUG ANTAGONISM;
INTRAVENOUS DRUG ADMINISTRATION;
AREA UNDER CURVE;
COMPARATIVE STUDY;
CYCLOSPORINE;
DOSE-RESPONSE RELATIONSHIP, DRUG;
HUMAN;
IMMUNOSUPPRESSIVE AGENTS;
INJECTIONS, INTRAVENOUS;
MALE;
PYRIDINES;
RECEPTORS, ENDOTHELIN;
TETRAZOLES;
VASODILATOR AGENTS;
HUMANS;
|
EID: 0036020408
PISSN: 00316970
EISSN: None
Source Type: Journal
DOI: 10.1007/s00228-002-0459-0 Document Type: Article |
Times cited : (19)
|
References (11)
|